Liesbeth Hoekman

23PUBLICATIONS
162CO-AUTHORS
Medical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsProteomics and metabolomicsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 28, 2026
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

|May 07, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

|Feb 13, 2026
DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

Nils Eickhoff, Liesbeth Hoekman, Onno Bleijerveld

|Dec 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.

Muddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam

|Sep 08, 2025
Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance.

Anna Dopler, Edwin S Kyei-Baffour, Mandy Kerkhoff

Pageof 4

Frequent Collaborators

9 joint publications

Onno Bleijerveld

6 joint publications

Maarten Altelaar

5 joint publications

Sebastian Gregoricchio

5 joint publications

Maaike Kreft